Harmony BiosciencesHRMY

那斯達克 · USD
34.40
-0.78
(-2.22%)
收盤 08/02 03:59 (UTC+8)
盤後 
(0%)
08/02 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 1.28
  • 1.19
  • 1.34
  • 1.60
  • 1.68
  • 1.55
  • 1.73
  • 1.86
  • 2.01
  • 1.85
icon
  • 9.47
  • -7.16
  • 12.67
  • 19.41
  • 5.08
  • -8.19
  • 11.77
  • 7.65
  • 8.19
  • -8.21
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
2023/Q1
2022/Q4
營業收入淨額
184,733
201,267
186,038
172,814
154,615
168,412
160,268
134,216
119,126
128,308
營業成本
31,99454,40942,77832,14427,48443,15232,29625,00820,78026,885
營業毛利
152,739
146,858
143,260
140,670
127,131
125,260
127,972
109,208
98,346
101,423
營業費用
96,494-81,550-75,09885,06463,46362,30657,92353,810
研發費用
34,54034,66625,38763,58322,18930,30617,49914,96913,28910,092
推銷及管理費用
61,95456,46556,16355,73152,90954,75845,96447,33744,63443,718
非經常性項目費用
----------
其他營業費用
----------
營業利益
56,245
55,727
61,710
21,356
52,033
40,196
64,509
46,902
40,423
47,613
其他收入及費用
4,7684,6374,8084,7424,2874,289-16,299-3,117273
利息費用
3,8364,2094,3484,4044,5354,796-3,622-3102,6453,583
稅前純益
57,177
56,155
62,170
21,694
51,785
39,689
51,832
44,095
37,780
44,103
所得稅
11,6176,68016,07710,10313,45113,08213,3719,7958,295-4,406
稅後純益
45,560
49,475
46,093
11,591
38,334
26,607
38,461
34,300
29,485
48,509
基本每股稅後盈餘(元)
0.790.870.810.200.680.460.640.570.490.82
稀釋每股稅後盈餘(元)
0.780.850.790.200.670.450.630.570.480.79
基本平均股數(千股)
57309.0057097.0056870.0056802.0056771.0058320.0059863.0059974.0059732.0059478.00
稀釋平均股數(千股)
58524.0058218.0058103.0057541.0057597.0058853.0060681.0060743.0061221.0061620.00
還原基本每股稅後盈餘(元)
0.790.870.810.200.680.460.640.570.490.82
還原稀釋每股稅後盈餘(元)
0.780.850.790.200.670.450.630.570.480.79
還原基本平均股數(千股)
57,30957,09756,87056,80256,77158,32059,86359,97459,73259,478
還原稀釋平均股數(千股)
58,52458,21858,10357,54157,59758,85360,68160,74361,22161,620
EBITDA(千元)
66,69666,01072,11131,70062,03050,11154,84649,59746,26953,744

大家都在看

HOT